• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于模式匹配和深度学习的肝硬化肝脏中≤2cm 小肝细胞癌的自动检测可行性研究。

Feasibility of automatic detection of small hepatocellular carcinoma (≤2 cm) in cirrhotic liver based on pattern matching and deep learning.

机构信息

Institute of Science and Technology for Brain-inspired Intelligence, Fudan University, Shanghai, People's Republic of China.

Department of Radiology, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, People's Republic of China.

出版信息

Phys Med Biol. 2021 Apr 16;66(8). doi: 10.1088/1361-6560/abf2f8.

DOI:10.1088/1361-6560/abf2f8
PMID:33780910
Abstract

Early detection of hepatocellular carcinoma (HCC) is crucial for clinical management. Current studies have reported large HCC detections using automatic algorithms, but there is a lack of research on automatic detection of small HCCs (sHCCs). This study is to investigate the feasibility of automatic detection of sHCC (≤2 cm) based on pattern matching and deep learning (PM-DL) model.. A retrospective study included 5376 image sets from 56 cirrhosis patients (28 sHCC patients with 32 pathologically confirmed lesions and 28 non-HCC cirrhosis patients) in the training-validation cohort to build and validate the model through five-fold cross-validation. In addition, an external test cohort including 6144 image sets from 64 cirrhosis patients (32 sHCC patients with 38 lesions and 32 non-HCC cirrhosis patients) was applied to further verify the generalization ability of the model. The proposed PM-DL model consisted of three main steps: 3D co-registration and liver segmentation, screening of suspicious lesions on diffusion-weighted imaging images based on pattern matching algorithm, and identification/segmentation of sHCC lesions on dynamic contrast-enhanced images with convolutional neural network.The PM-DL model achieved a sensitivity of 89.74% and a positive predictive value of 85.00% in the external test cohort for per-lesion analysis. No significant difference was observed in volumes (= 0.13) and the largest sizes (= 0.89) between manually delineated and segmented lesions. The DICE coefficient reached 0.77 ± 0.16. Similar performances were identified in the validation cohort. Moreover, the PM-DL model outperformed Liver Imaging Reporting and Data System (LI-RADS) in sensitivity (probable HCCs: LR-5 or LR-4,= 0.18; definite HCCs: LR-5,< 0.001), with a similar high specificity for per-patient analysis.. The PM-DL model may be feasible for accurate automatic detection of sHCC in cirrhotic liver.

摘要

肝细胞癌 (HCC) 的早期检测对于临床管理至关重要。目前的研究已经报道了使用自动算法对大 HCC 进行检测,但对于小 HCC(sHCC)的自动检测研究较少。本研究旨在探讨基于模式匹配和深度学习(PM-DL)模型对 sHCC(≤2cm)进行自动检测的可行性。一项回顾性研究纳入了 56 例肝硬化患者(28 例 sHCC 患者,32 个经病理证实的病灶;28 例非 HCC 肝硬化患者)的 5376 个图像集,用于构建和验证模型,通过五重交叉验证。此外,还应用了一个包含 64 例肝硬化患者(32 例 sHCC 患者,38 个病灶;32 例非 HCC 肝硬化患者)的 6144 个图像集的外部测试队列,以进一步验证模型的泛化能力。所提出的 PM-DL 模型由三个主要步骤组成:3D 配准和肝脏分割、基于模式匹配算法在弥散加权成像图像上筛选可疑病灶、以及使用卷积神经网络在动态对比增强图像上识别/分割 sHCC 病灶。在外部测试队列中,对病灶进行分析,PM-DL 模型的敏感度为 89.74%,阳性预测值为 85.00%。手动勾画和分割病灶的体积(=0.13)和最大尺寸(=0.89)无显著差异。DICE 系数达到 0.77±0.16。在验证队列中也得到了类似的性能。此外,PM-DL 模型在敏感度方面优于肝脏影像报告和数据系统(LI-RADS)(可能 HCCs:LR-5 或 LR-4,=0.18;明确 HCCs:LR-5,<0.001),对于每位患者的分析具有相似的高特异性。PM-DL 模型可能是肝硬化中 sHCC 准确自动检测的一种可行方法。

相似文献

1
Feasibility of automatic detection of small hepatocellular carcinoma (≤2 cm) in cirrhotic liver based on pattern matching and deep learning.基于模式匹配和深度学习的肝硬化肝脏中≤2cm 小肝细胞癌的自动检测可行性研究。
Phys Med Biol. 2021 Apr 16;66(8). doi: 10.1088/1361-6560/abf2f8.
2
Automatic segmentation of hepatocellular carcinoma on dynamic contrast-enhanced MRI based on deep learning.基于深度学习的动态对比增强磁共振成像对肝细胞癌的自动分割
Phys Med Biol. 2024 Mar 12;69(6). doi: 10.1088/1361-6560/ad2790.
3
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.在一项多中心回顾性研究中,1006 个结节的对比超声 LI-RADS LR-5 可识别肝硬化中的肝细胞癌。
J Hepatol. 2018 Mar;68(3):485-492. doi: 10.1016/j.jhep.2017.11.007. Epub 2017 Nov 11.
4
Deep learning-assisted LI-RADS grading and distinguishing hepatocellular carcinoma (HCC) from non-HCC based on multiphase CT: a two-center study.深度学习辅助的 LI-RADS 分级和基于多期 CT 鉴别肝细胞癌(HCC)与非 HCC:一项双中心研究。
Eur Radiol. 2023 Dec;33(12):8879-8888. doi: 10.1007/s00330-023-09857-w. Epub 2023 Jul 1.
5
[Texture analysis of diffusion-weighted magnetic resonance imaging to identify atypically enhanced small hepatocellular carcinoma and dysplastic nodules under the background of cirrhosis].[磁共振扩散加权成像纹理分析鉴别肝硬化背景下非典型强化小肝细胞癌及发育异常结节]
Zhonghua Gan Zang Bing Za Zhi. 2020 Jan 20;28(1):37-42. doi: 10.3760/cma.j.issn.1007-3418.2020.01.010.
6
Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.肝硬化中肝细胞癌的检测:对比增强 CT 与 MRI 联合细胞外对比剂及钆塞酸二钠的诊断性能比较。
Eur Radiol. 2020 Feb;30(2):1020-1030. doi: 10.1007/s00330-019-06458-4. Epub 2019 Oct 31.
7
Differentiation of small (≤ 3 cm) hepatocellular carcinomas from benign nodules in cirrhotic liver: the added additive value of MRI-based radiomics analysis to LI-RADS version 2018 algorithm.小肝癌(≤3cm)与肝硬化肝脏良性结节的鉴别:基于 MRI 的放射组学分析对 LI-RADS 版本 2018 算法的附加附加价值。
BMC Gastroenterol. 2021 Apr 7;21(1):155. doi: 10.1186/s12876-021-01710-y.
8
Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging.使用磁共振成像对肝细胞癌进行无创诊断时LI-RADS 2018与KLCA-NCC 2018的比较
Clin Mol Hepatol. 2020 Jul;26(3):340-351. doi: 10.3350/cmh.2020.0004. Epub 2020 Jun 4.
9
Prevalence and clinical significance of discordant LI-RADS observations on multiphase contrast-enhanced MRI in patients with cirrhosis.肝硬化患者多期增强 MRI 上 LI-RADS 观察结果不一致的流行率和临床意义。
Abdom Radiol (NY). 2020 Jan;45(1):177-187. doi: 10.1007/s00261-019-02133-w.
10
Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.超声造影对肝细胞癌鉴别诊断的诊断准确性:爱克发与CEUS-LI-RADS对比
Eur J Gastroenterol Hepatol. 2017 Sep;29(9):1036-1044. doi: 10.1097/MEG.0000000000000916.

引用本文的文献

1
Application of artificial intelligence in the diagnosis of hepatocellular carcinoma.人工智能在肝细胞癌诊断中的应用。
eGastroenterology. 2023 Nov 30;1(2):e100002. doi: 10.1136/egastro-2023-100002. eCollection 2023 Sep.
2
Deep Learning Methods in Medical Image-Based Hepatocellular Carcinoma Diagnosis: A Systematic Review and Meta-Analysis.基于医学图像的肝细胞癌诊断中的深度学习方法:系统评价与荟萃分析
Cancers (Basel). 2023 Dec 3;15(23):5701. doi: 10.3390/cancers15235701.
3
Artificial Intelligence in the Diagnosis of Hepatocellular Carcinoma: A Systematic Review.
人工智能在肝细胞癌诊断中的应用:一项系统综述。
J Clin Med. 2022 Oct 28;11(21):6368. doi: 10.3390/jcm11216368.
4
Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound.肝细胞癌的影像学诊断:特别强调肝胆磁共振成像和对比增强超声的未来方向。
Clin Mol Hepatol. 2022 Jul;28(3):362-379. doi: 10.3350/cmh.2021.0361. Epub 2021 Dec 27.
5
Progress of MRI Radiomics in Hepatocellular Carcinoma.肝细胞癌磁共振成像放射组学的研究进展
Front Oncol. 2021 Sep 20;11:698373. doi: 10.3389/fonc.2021.698373. eCollection 2021.